Clinical Trial Update: Walnut Oral Immunotherapy for Tree Nut Allergy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating walnut oral immunotherapy for tree nut allergy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tree Nut Allergy

Drugs mentioned

• Walnut Oral Immunotherapy

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Nut Hypersensitivities | Phase 1, Phase 2 | Status: WITHDRAWN